Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Sep 6, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, routine-disclosure, foreign-private-issuer
TL;DR
Dr. Reddy's Labs filed a standard 6-K, confirming its Indian HQ and 20-F filing status.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on September 6, 2024, to report information as a foreign private issuer. The filing confirms the company's principal executive office is located in Hyderabad, Telangana, India, and that it files annual reports under Form 20-F.
Why It Matters
This filing is a routine disclosure for foreign private issuers, providing standard corporate information to the SEC and investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing with no new financial or operational information disclosed.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Filer
- Hyderabad, Telangana, India (location) — Principal executive office location
- September 6, 2024 (date) — Filing date
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information as a foreign private issuer to the U.S. Securities and Exchange Commission (SEC).
Where is Dr. Reddy's Laboratories Limited's principal executive office located?
Dr. Reddy's Laboratories Limited's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Limited file annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories Limited indicates that it files annual reports under cover of Form 20-F.
What is the SEC file number for Dr. Reddy's Laboratories Limited?
The SEC file number for Dr. Reddy's Laboratories Limited is 1-15182.
What is the SIC code for Dr. Reddy's Laboratories Limited?
The Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-09-06 06:15:51
Filing Documents
- drr0667_6k.htm (6-K) — 13KB
- drr0667_ex99-1.htm (EX-99.1) — 5KB
- drr0667_ex99-1img01.jpg (GRAPHIC) — 2KB
- drr0667_ex99-1img02.jpg (GRAPHIC) — 4KB
- 0001575872-24-000988.txt ( ) — 29KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 06, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3